🇺🇸

Broad Market

· daily

US Material Events SEC 8-K Filings — July 23, 2026

The July 23, 2026, filing batch reveals a market dominated by capital market events (SPAC IPOs, debt financings, and at-the-market offerings) and significant corporate actions (M&A, divestitures, and leadership transitions). Key period-over-period trends show a mixed earnings picture in the industrial and auto-tech sectors, with Gentherm and Visteon reporting divergent results: Gentherm posted record revenue (+11% YoY) but suffered a sharp cash flow decline, while Visteon saw a 31% drop in net income. A clear sector theme is the aggressive restructuring and refocusing of smaller-cap companies, with several firms divesting non-core assets (LightPath, Tharimmune) or expanding via acquisition (HF Foods, Vireo Growth) to improve financial profiles and growth trajectories. Insider activity was limited to compensation-driven equity grants, providing no clear conviction signals, but forward-looking guidance changes (Gentherm raising full-year revenue outlook) and a flurry of new financing facilities (ADTRAN, Virtu Financial) point to a strategic push for liquidity and growth capital. The most critical developments include the Vireo Growth acquisition of distressed Cannabist assets, the HF Foods cross-border expansion, and the significant CFO transitions at GE HealthCare and Coastal Financial, all of which carry material implications for their respective sectors.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — July 23, 2026

The 42 filings from July 23, 2026, reveal a high-stakes environment dominated by insolvencies, delistings, and strategic M&A. Key themes include a wave of Nasdaq delisting risks (5 companies), active insolvency proceedings (3 companies with NCLT involvement), and a flurry of M&A activity in India, particularly in the mid-cap and specialty sectors. Period-over-period data shows mixed financial health: Gentherm posted record revenue (+11% YoY) but with margin compression (-70 bps) and a sharp cash flow decline (-93% YoY), while Tharimmune's divestiture improved its pro forma net loss by 28% but left it with a massive deferred tax liability. Insider activity is sparse, but the lack of insider tendering in several tender offers (Crestline, Fortress) signals low management conviction. Capital allocation trends show a shift towards buybacks (Gentherm's new $400M program) and strategic acquisitions for growth, while several companies face existential risks from non-compliance with listing standards. The most critical developments are the potential delisting of Nuvve and the insolvency of Manaksia Coated Metals, both with high materiality and immediate market implications.

42 high priority 42 total filings
· daily

US SEC Filings Daily Market Digest — July 23, 2026

Today's filings reveal a market characterized by strong top-line growth but significant margin compression and rising leverage across key sectors. Tech giants Alphabet and Tesla posted robust revenue growth of 24% and 26% YoY, respectively, yet Tesla's net income fell 5% due to a 57% operating income decline, highlighting cost pressures. Financials showed mixed results: KB Financial Group's H1 operating revenue surged 42% YoY, while regional banks like Independent Bank Corp and Northrim BanCorp reported improved net interest margins but sharp increases in non-performing loans. A notable capital allocation divergence is emerging—Alphabet's long-term debt surged 111% and goodwill rose 73%, suggesting aggressive M&A, while Comcast paused its buyback program amid a planned spin-off. Insider activity was sparse but included a concerning board member removal at Vale for leaking confidential information. The most actionable themes are the divergence in profitability within tech, the NIM expansion vs. credit quality trade-off in regional banking, and the growing use of debt-financed growth strategies.

15 high priority 35 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 23, 2026

Overnight filings reveal a market bifurcated between strong operational performance and rising strategic uncertainty. Columbia Financial Inc. saw an extraordinary wave of insider buying, with 12 executives and directors collectively purchasing over $3.3 million of stock at $10.00 per share, signaling profound conviction in a deeply undervalued asset. Conversely, a high-stakes governance battle is unfolding at Hilltop Holdings, where the largest shareholder (26.7% stake) is voting against all directors and executive compensation, creating significant headline risk. On the earnings front, Alphabet and Thermo Fisher delivered standout results, with revenue surging 24% and 10% respectively, though Alphabet's massive net income jump was driven by non-operating items. Tesla's Q2 showed a worrying divergence: revenue grew 25.5% YoY, but operating income collapsed 56.9% due to soaring expenses, and regulatory credit revenue plunged 67%. Comcast's mixed report highlighted a strategic pivot, with a share repurchase pause and record wireless additions, but continued broadband losses. A key portfolio-level trend is the divergence in capital allocation: while Allegion aggressively bought back shares (+101% YoY), Comcast paused its program, signaling different stages of corporate lifecycle and strategic transformation.

35 high priority 15 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — July 22, 2026

The July 22, 2026 filings reveal a market dominated by transformative M&A and strategic capital events, with three major acquisitions (Public Storage/NSA, Progress Software/Domo, Vita Coco/Copra) totaling over $575 million in disclosed value, signaling consolidation in self-storage, enterprise software, and consumer staples. Leadership transitions are widespread, with 15+ filings involving C-suite or board changes, including significant CEO successions at Jackson Financial and FirstCash Holdings, though most appear planned and orderly. Financial health signals are mixed: RPM International reported record sales with 7.2% YoY growth but GAAP net income declined 2%, while First Community Corp posted a 46.5% YoY net income surge driven by acquisition synergies. Several micro-cap companies face acute distress, including NEXT-ChemX (change of control, $1.61M debt default), 20/20 Biolabs (Nasdaq delisting risk), and Onar Holding (costly $1.5M litigation settlement), creating a bifurcated landscape where well-capitalized firms execute growth strategies while weaker entities struggle for survival. The most actionable theme is the convergence of AI and data readiness, with Progress Software's $400M Domo acquisition and Guidewire's AI-focused board appointment highlighting corporate urgency to capture AI-driven productivity gains.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — July 22, 2026

The July 22, 2026 filing batch reveals a market dominated by major M&A finalizations and a wave of insolvency/restructuring activity, primarily in Indian markets. The most significant event is the completion of the Public Storage/National Storage Affiliates Trust merger, creating a self-storage behemoth with over 4,500 properties and expected run-rate synergies of $110-$130 million. Concurrently, a cluster of Indian companies are navigating insolvency resolution, with SAB Events & Governance Now Media facing a severe 100:5 share reduction for public holders. A notable trend is the high volume of SPAC-related filings, including a new $200 million IPO by Jones Ventures and a 9-month extension by Hudson Acquisition I Corp, signaling continued activity but also challenges in finding targets. Delisting actions are prominent, with SunPower and Microvast receiving Nasdaq notices, while CAE INC voluntarily withdrew from the NYSE. The period-over-period data highlights strong growth in niche areas like freeze-dried foods (Tejassvi Aaharam's target grew 366% YoY) and premium beverages (United Spirits' target grew 821% YoY), contrasting with the distressed situations of companies under CIRP.

45 high priority 45 total filings
· daily

US SEC Filings Daily Market Digest — July 22, 2026

Today's filings reveal a market bifurcated between commodity-driven strength and consumer/industrial headwinds. Southern Copper and Vale posted record or strong production results, buoyed by high metal prices, while Cal-Maine Foods experienced a severe earnings collapse due to an egg oversupply. The technology sector shows a divergence, with Otis Worldwide's new equipment business in China slumping, contrasting with SK hynix's massive $5.1B AI memory investment. A notable theme is corporate restructuring for strategic realignment, as seen with monday.com's 20% workforce reduction and Passage Bio's pivot to RNA-modulating therapies. The financial sector is mixed, with Santander reporting record profits but rising provisions, while the XFLT proxy fight highlights significant distress in CLO equity markets. Insider activity is sparse, but a major Temasek stake reduction in Flywire and a change of control at NEXT-ChemX are key signals. Capital allocation trends show a mix of aggressive reinvestment (SK hynix, Southern Copper) and shareholder returns (Cal-Maine buybacks), with a notable increase in dilutive financing activities (RedCloud ATM, ATA Creativity PIPE).

5 high priority 45 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 22, 2026

Overnight SEC filings reveal a market bifurcated between strong operational performance in select industrial and commodity sectors and significant headwinds in consumer staples, airlines, and technology. Cal-Maine Foods' 49.9% YoY revenue decline and net loss highlight a severe egg industry oversupply, while Southern Copper's record 40.6% revenue growth and 71.6% net income surge underscore a commodity super-cycle. Insider selling is pronounced, with United Airlines' CEO selling $18.8M in stock and multiple director-level sales at Western Digital and Kaspi.kz, signaling management caution. Conversely, SK hynix's $5.1B AI memory investment and monday.com's strategic restructuring (20% workforce cut) point to aggressive positioning for AI-driven growth. Capital allocation trends are mixed: Cal-Maine repurchased $30.1M in shares despite losses, while Banco Santander's record H1 profit was offset by rising provisions. Portfolio-level patterns show a clear divergence between commodity producers (copper, iron ore) benefiting from price inflation and consumer-facing companies (eggs, airlines) facing demand normalization. The most critical development is the Braskem debt restructuring impasse, where holders proposed ~R$50B in terms deemed 'far from acceptable,' posing a systemic risk to Brazilian credit markets.

15 high priority 35 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — July 21, 2026

This digest covers 50 filings from July 21, 2026, revealing a market dominated by capital structure maneuvers, SPAC activity, and leadership transitions. The most significant themes are a wave of SPAC IPOs and business combination failures (FACT II, Twenty One Capital pivot), aggressive M&A in the consumer and defense sectors (Starco Brands, Innovative Aerosystems), and a notable number of distressed situations (Vicarious Surgical liquidation, Splash Beverage cash crunch). Period-over-period data was sparse in these event-driven filings, but where available, it showed strong performance (First Financial Bancorp record EPS up 8% YoY) alongside clear warning signs (Splash Beverage missed payments). Insider activity was limited, but the resignation of a director over a D&O insurance lapse at ClimateRock is a significant governance red flag. The overall sentiment is mixed, with a clear bifurcation between companies executing strategic growth and those facing existential challenges.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — July 21, 2026

The July 21, 2026 filings reveal a day of extreme corporate distress and strategic realignment, dominated by a wave of insolvencies and liquidations. The most critical development is the liquidation of **Vicarious Surgical Inc.**, where stockholders are expected to receive nothing, and the Nasdaq delisting of **CN Healthy Food Tech Group Corp.**, which faces an existential appeal deadline. A significant cluster of three filings from **Simbhaoli Sugars Limited** shows its CIRP process finally moving forward after a stay was vacated, but the company remains deeply distressed with over ₹1.08 Cr in admitted claims. On the M&A front, **Gabriel India's** $98.44M acquisition of a 30% stake in HL Klemove India stands out as a high-growth bet on autonomous driving, while the **Bliss GVS Pharma** open offer at ₹299/share creates a potential arbitrage opportunity. The SPAC sector is active but troubled, with **FACT II Acquisition Corp.** terminating its deal and several others (Aeon, Horizon) taking on debt to fund searches. Period-over-period data from **MPS Limited** shows a strong 42.5% YoY net profit surge, while **Northpointe Bancshares** shows margin compression. The day's filings paint a picture of a market bifurcated between aggressive capital deployment for growth and the final throes of insolvency.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — July 21, 2026

Today's filings reveal a mixed picture with several high-profile SPAC transactions and corporate actions driving activity. Key themes include a significant SPAC merger valuing Terra Quantum at $3.5B, a contested tender offer for Lisata Therapeutics with financing issues, and a proxy fight at XAI Octagon over sub-adviser underperformance. Financial sector filings show mixed results: Synchrony Financial reported record purchase volume (+8% YoY) but earnings declined 8% due to higher provisions, while Cementos Pacasmayo posted strong EBITDA growth (+34.3% YoY) but margin contraction in cement. Insider activity was limited, with notable insider selling at KB Financial Group (largest shareholder reduced stake). Capital allocation trends include Energy Transfer's $1.75B debt issuance and Novo Nordisk's ongoing buyback. Several routine foreign issuer filings provided minimal new information.

10 high priority 40 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 21, 2026

Overnight SEC filings reveal a mixed but cautious tone ahead of today's open, with a notable cluster of insider selling at high materiality levels. SharkNinja's CEO sold $38.8M in stock under a 10b5-1 plan, while Madrigal Pharmaceuticals' CEO exercised and sold options worth $372K, both generating bearish signals. The most critical development is an activist filing at Phunware, where Goldenwise Capital disclosed a 6.9% stake, publicly criticized governance, and threatened a proxy contest—the highest materiality event of the session. In the financial sector, Northfield Bancorp saw a wave of insider dispositions to the issuer, including the CEO returning 464K shares, suggesting a capital return event. On the positive side, Fulcrum Therapeutics saw a 10% owner buy $594K worth of stock, a bullish insider signal. Period-over-period data was limited in these filings, but the concentration of insider selling in biotech and consumer goods, combined with activist pressure at Phunware and a dilutive financing at VisionWave, points to a cautious market tone with select activist and insider-buying opportunities.

43 high priority 7 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — July 20, 2026

Today's digest (July 20, 2026) is eventful, dominated by a major SPAC merger filing (DRC Medicine/Ribbon Acquisition), a high-profile IPO (Jersey Mike's Subs), a significant corporate restructuring (Flex Ltd. spin-off), and a mining sector consolidation (Gold Resource Corp/Goldgroup). Enriched period data reveals a clear divergence: consumer-facing names like Domino's Pizza are showing pronounced same-store sales stagnation (US +0.1%, Int'l -0.1%), while assets like Investar Holding Corp demonstrate mixed results with a strong YoY earnings recovery (+98% YoY, albeit down QoQ). A notable cluster of auditor changes and financial restatements create risk flags across micro-cap names like Adapti and Spectral Capital. Insider activity is sparse, with the most material being a newly filed controlling 75% stake in Margaree Acquisition Corp. Capital allocation trends are mixed, with a healthy IPO pipeline and SPAC activity alongside a concerning lack of revenue generation at Alternus Clean Energy. The 13F filings paint a broadly neutral picture, showing large institutional portfolios heavily tilted towards fixed-income ETFs and mega-cap tech, suggesting a 'risk-off but with concentrated bets' stance. Key catalysts to watch include the DRC Medicine SPAC shareholder vote, Jersey Mike's pricing, and the continued MHRA decision for Northwest Biotherapeutics.

11 high priority 39 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 20, 2026

This pre-market digest covers 50 filings, with a heavy concentration of 13F-HR institutional holdings updates (12 filings) that provide a snapshot of Q2 2026 positioning but lack period-over-period comparisons. The most actionable themes center on corporate actions: Jersey Mike's Subs is moving forward with a high-profile IPO (expected price range $21-$25), while DRC Medicine's SPAC merger with Ribbon Acquisition Corp is progressing (DRC holders to own ~85.78% of the combined entity). In the energy and mining space, Gold Resource Corp is being acquired by Goldgroup Mining, with the combined entity trading under 'GORO'. Domino's Pizza reported a sharp deceleration in US same-store sales (0.1% vs 3.4% a year ago), signaling a potential consumer spending slowdown. Flex Ltd. announced a major strategic spin-off of its Cloud and Power Infrastructure segment, achieving its FY27 margin target a year early. Insider activity is limited, but a controlling stake disclosure in Margaree Acquisition Corp (75% by Mark N. Tompkins) and a significant stake increase by Korea's NPS in Shinhan Financial Group (to 9.19%) are notable. The most critical risks include a financial restatement at Adapti, Inc. and a going concern warning from Spectral Capital Corp. The overall tone is mixed, with several high-conviction corporate events offset by operational headwinds in consumer-facing sectors.

11 high priority 39 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — July 17, 2026

The July 17, 2026, filing cycle reveals a market dominated by significant capital markets activity, with a major IPO ($1.01B for Csquare), a large convertible note offering ($650M+ for Penguin Solutions), and a $1.14B ABS securitization by Uniti Group. The most critical development is the receivership of Fuse Science, a terminal event for a micro-cap, while the sector sees a major strategic pivot in biotech with Jasper Therapeutics' dilutive acquisition of Kira Pharmaceuticals. A clear theme of financial distress and restructuring is evident, with companies like Trans American Aquaculture restating financials, Generation Income Properties fighting for Nasdaq compliance, and EyePoint Pharmaceuticals settling a False Claims Act case. On the positive side, there is a wave of strategic M&A, including IPG Photonics' acquisition of Lumibird Medical and several SPACs (Four Leaf, Mercator) pursuing new combinations. Leadership changes are widespread, but the most impactful are the CFO transitions at Energy Vault and Lindsay Corp, and the CEO transition at Adobe, which is triggering retention packages. Overall, the period is characterized by aggressive capital raising, strategic repositioning, and a clear bifurcation between companies with strong growth narratives and those facing existential challenges.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — July 17, 2026

The July 17, 2026, filing set reveals a market dominated by corporate restructuring, insolvency proceedings, and strategic M&A, with a notable concentration of distress in Indian real estate and financial services. Key period-over-period trends include significant revenue declines from asset sales (Braemar Hotels: -18% pro forma revenue drop) and margin compression from regulatory penalties (Jana Small Finance Bank: 22.5% NPA divergence). The most critical developments are the appointment of a receiver for Fuse Science (insolvent, $0 assets), Nasdaq delisting threats for Actuate Therapeutics and Dare Bioscience, and a transformative 99% capital reduction at Oxford Industries following a change in control. Portfolio-level patterns show a surge in SPAC activity (4 IPOs/amendments) and a wave of Indian insolvency updates (7 filings), signaling a bifurcated market where capital is flowing to new blank-check vehicles while legacy entities face liquidation or restructuring. The overall sentiment is cautiously negative, with 18 filings carrying negative or mixed sentiment, but pockets of opportunity exist in renewable energy (DCM Shriram) and aerospace (NRB Bearing).

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — July 17, 2026

Across 50 SEC filings for July 17, 2026, three dominant themes emerge: (1) pronounced capital actions and M&A activity driving near-term catalysts (Dominion/NextEra S-4 filings, IPG/Lumibird bid, Jasper/Kira all‑stock + PIPE, multiple SPAC IPOs/extensions); (2) mixed financial performance across banks and industrials with earnings dispersion — regional banks show resilient fee income but margin pressure (Truist, Regions, Fifth Third), while select industrials/energy report restructuring charges and asset impairments (Autoliv, Frequency Electronics, BHP); (3) significant dilution and financing maneuvers at smaller growth/tech names (AITX reverse split and share regime changes, NovaBridge equity plan, multiple SPACs). Period-over-period comparisons show revenue growth >20% YoY in pockets (AITX device rental +37% driving +26% revenue YoY), while several companies report margin compression (Frequency Electronics gross margin down ~1,400 bps YoY to 29.1%). Material developments with market implications: Dominion/NextEra combination (expected close H2 2027) is the largest regulatory/catalyst event and may re-rate regulated utility exposures; Jasper/Kira transaction materially dilutes legacy holders but funds operations into 2H 2028 and creates a biotech pipeline with milestone CVR upside; IPG’s €300M Lumibird Medical offer is accretive to margin and expands medical laser exposure. Portfolio-level patterns: SPAC activity remains elevated (multiple new IPOs, unit separations, deadline extensions) signaling continuing sponsor-driven deal flow; insider moves are meaningful in select filings (Jefferies large buy by SMFG, exercises by directors) and indicate conviction in financials or compensation settlements. Immediate market actions should prioritize monitorable near-term catalysts (Dominion regulatory filings, IPG close expected Q4 2026, Jasper clinical milestones to 2028, MakeMyTrip Indian IPO process) while de-risking names with cash erosion, high short-term liabilities, or ongoing deregistration filings (Sigyn, AITX liquidity stress).

28 high priority 22 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 17, 2026

Overnight SEC filings reveal a market bifurcated between aggressive capital deployment and fundamental deterioration. The most dominant theme is a wave of transformative M&A and capital markets activity, including NextEra Energy's $2.25 billion deal to acquire Dominion Energy, IPG Photonics' €300 million acquisition of Lumibird Medical, and Jasper Therapeutics' dilutive $132 million PIPE-funded merger with Kira Pharmaceuticals. However, this optimism is counterbalanced by severe operational stress in several sectors. Frequency Electronics reported a dramatic swing from a $23.7M profit to a $0.9M loss, while AITX's cash position dwindled to just $95K against $44.9M in current liabilities. Insider activity is sending mixed signals: a massive $319M purchase by Sumitomo Mitsui in Jefferies Financial Group signals strong institutional conviction, while a $1.8M sale by Marvell's Data Center President raises questions about peak valuation. The financial sector shows a clear divergence, with Truist and Fifth Third posting strong YoY earnings growth driven by fee income and M&A integration, while Regions Financial reported flat revenue and elevated net charge-offs. The SPAC market remains active but challenged, with Papaya Growth's cash trust depleting and Sigyn Therapeutics deregistering entirely, highlighting the ongoing shakeout in blank-check companies.

29 high priority 21 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — July 16, 2026

The July 16, 2026 filings reveal a market dominated by transformative M&A and distressed restructuring, with significant capital flowing into neuroscience, solar infrastructure, and defense technology. Key period-over-period trends are limited as most filings lack comparative financials, but notable exceptions include a high-margin acquisition (8.8x EBITDA) and a distressed debt-for-equity swap. The most critical developments are Eli Lilly's $3.8B acquisition of atai Life Sciences for its depression pipeline, Uber's $14.8B bid for Delivery Hero, and the bankruptcies of Inotiv and SpringBig, which signal a bifurcated market where well-capitalized firms aggressively consolidate while over-leveraged names face extinction. Insider activity is sparse but includes a CEO's performance-based RSU grant tied to a $100B value creation target. Portfolio-level patterns show a clear tilt toward neuroscience, solar infrastructure, and rare earth supply chains, with capital allocation favoring debt restructuring and strategic acquisitions over dividends.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — July 16, 2026

The 42 filings from July 16, 2026, reveal a market sharply bifurcated between aggressive corporate restructuring and acute financial distress. A dominant theme is the wave of M&A and capital realignment, particularly in India, where companies like Aurum PropTech, HCLTech, and RSC International are executing high-value acquisitions and share swaps to consolidate market positions. Concurrently, a significant number of entities are facing existential threats: Inotiv, Winsome Yarns, and SpringBig Holdings are undergoing Chapter 11 or insolvency processes that will wipe out existing equity holders, while Mangalam Drugs and Cycurion face imminent default and delisting risks. The data shows a clear pattern of 'haves' using strong balance sheets to acquire growth, and 'have-nots' succumbing to debt and regulatory pressures. Insider activity is sparse but telling, with the Kobo Biotech insolvency failure and the Chart Industries/Baker Hughes merger completion representing the most material events. The forward-looking calendar is packed with shareholder meetings and regulatory deadlines, particularly in August 2026, which will be a critical month for many of these corporate actions.

42 high priority 42 total filings